Novel therapy for treating cardiogenic shock
- Cardio
- 01/11/2017
A new study aims to assess the effectiveness of a novel therapy for treating cardiogenic shock and patients undergoing high-risk percutaneous intervent
READ MOREA new study aims to assess the effectiveness of a novel therapy for treating cardiogenic shock and patients undergoing high-risk percutaneous intervent
READ MORETriple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for...
READ MOREStress is a leading risk factor for heart disease and hypertension, which can impact a patient's quality of life. To deal with their stress, patients...
READ MOREA large, population-based study demonstrates the safety and long-term benefits of multiple arterial grafting (MAG) among patients undergoing coronary...
READ MOREPeripartum cardiomyopathy (PPCM) is a form of heart failure that occurs in the last month of pregnancy or up to five months following delivery. This...
READ MOREA new U.S. study shows that coordinated, multifaceted public health initiatives may be helpful for communities aiming to improve outcomes of out-of-hos
READ MOREResearchers at Texas Heart Institute's Cardiomyocyte Renewal Lab have found a new way to help improve heart function following heart failure. Using...
READ MORECholesterol lowering medications PCSK9 inhibitors (PCSK9i), alirocumab and evolocumab, were approved in 2015. Their high cost however has led to...
READ MOREResults of a new study indicate that rise in maternal blood pressure during pregnancy and pregnancy hypertension, independent of maternal body size...
READ MORE8th Emirates Cardiac Society Congress in Collaboration with ACC Middle East Conference 2017
READ MORE